---
title: "Key facts: 12.5% of Patients Achieve Major Weight Loss with Novo Nordisk; Company Wins HPC Innovation Award"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/266652389.md"
description: "Research on over 135,000 patients found that 12.5% were 'super responders' to Novo Nordisk's GLP-1 drugs, achieving over 15% weight loss in a year, highlighting potential for tailored treatments.1Novo Nordisk, with SiC Systems and ORCA Computing, won the 2025 HPC Innovation Excellence Award for AI and quantum computing research to identify faults in biomanufacturing, promising cost savings.2"
datetime: "2025-11-20T02:03:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/266652389.md)
  - [en](https://longbridge.com/en/news/266652389.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/266652389.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/266652389.md) | [繁體中文](https://longbridge.com/zh-HK/news/266652389.md)


# Key facts: 12.5% of Patients Achieve Major Weight Loss with Novo Nordisk; Company Wins HPC Innovation Award

-   Research on over 135,000 patients found that 12.5% were 'super responders' to Novo Nordisk's GLP-1 drugs, achieving over 15% weight loss in a year, highlighting potential for tailored treatments.1
-   Novo Nordisk, with SiC Systems and ORCA Computing, won the 2025 HPC Innovation Excellence Award for AI and quantum computing research to identify faults in biomanufacturing, promising cost savings.2

### 相关股票

- [Novo Nordisk AS (NVO.US)](https://longbridge.com/zh-CN/quote/NVO.US.md)

## 相关资讯与研究

- [Novo Nordisk slashes Wegovy prices to court uninsured patients](https://longbridge.com/zh-CN/news/281206892.md)
- [Novo Nordisk Launches Discounted Subscription Program for Wegovy Obesity Drugs -- Update](https://longbridge.com/zh-CN/news/281201382.md)
- [Novo Nordisk Updates Articles of Association and Capital Increase Mandate](https://longbridge.com/zh-CN/news/280807928.md)
- [Novo Nordisk A/S Approves Board Changes](https://longbridge.com/zh-CN/news/280694583.md)
- [Novo Nordisk A/S Approves Final Dividend for 2025, Payable in March 2026](https://longbridge.com/zh-CN/news/280694679.md)